Medicare Programs
Expert articles and analysis related to medicare programs.
AI Summary — Last 24 Hours
In the past week, CMS has frozen enrollment in Elevance Health's Medicare Advantage-Prescription Drug Plans due to ongoing noncompliance with risk adjustment and data submission requirements, signaling heightened scrutiny on Medicare Advantage plans amid evolving regulatory dynamics. Concurrently, CMS has extended the Acute Hospital Care at Home waivers through 2030, reinforcing the commitment to enhancing home care options for Medicare patients, which could alleviate capacity pressures in traditional healthcare settings. Additionally, Medicare's support for telehealth services has been secured through the end of 2027, reflecting a growing trend towards virtual care as a stable alternative to in-person visits amidst ongoing healthcare transformations. For further details, see the reports on Elevance's enrollment freeze and hospital-at-home waivers.
Related Articles
Costs loom amid evolving trans care policies
Hospitals urged CMS to withdraw proposed rules aimed at barring “sex-rejecting procedures” on children, while others warned of costs. Several hospital groups raised objections to two proposed rules fr...
Humana expands cardiac care partnerships for Medicare Advantage
Humana has expanded its cardiac care program through new partnerships with Karoo Health, US Heart and Vascular and Chamber Cardio. The partnership builds on its existing collaboration with CVAUSA’s No...
Analyzing Changes in Medicare Part D Enrollment for 2026
The Medicare Part D prescription drug benefit is provided by private plans, either Medicare Advantage plans that offer drug coverage (MA-PDs) or, for those in traditional Medicare, stand-alone prescri...
6 Texas physicians to pay $5M to settle false claims allegations
Six South Texas physicians and their practices agreed to pay $4.9 million to resolve allegations they submitted false claims to Medicare, Medicaid and TriCare for services that were not rendered or no...
Opinion: CMS shouldn’t be paying for higher-than-necessary doses of cancer drugs
In cancer treatment, higher doses with worse side effects often don’t lead to better outcomes.
ASC vs. HOPD costs for 5 orthopedic procedures
Across five orthopedic procedures—including two that were added to the Covered Procedures List for 2026— ASCs consistently post lower total costs than hospital outpatient departments — in some cases b...
Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
La inflación médica ha superado de manera constante la inflación general durante años, y las facturas de muchos procedimientos breves y de rutina llegan a decenas de miles de dólares.
Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
Health care prices are on the rise, and patients are flummoxed that even insurance companies aren’t doing more to control costs.
Real world experience with insurers pushing back on copay cards
As reported by Kaiser Health News: The value of drugmakers’ copay cards has become more unpredictable as insurers try to restrict their use. Many insurance plans, for instance, do not count the money ...